Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol versus dexmedetomidine for sedation after coronary artery bypass graft surgery
IRCT20240207060924N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of propofol and dexmedetomidine in coronary arteriosclerosis (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Mean arterial pressure, Pulse rate and 4 more. Started Feb 2024; status: completed.
02
Drugs
propofoldexmedetomidine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20240207060924N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240207060924N1.